| 发明名称 | Methods for the treatment of hepatitis B and hepatitis D virus infections | ||
| 摘要 | It is disclosed a method for treating hepatitis B virus infection or hepatitis B virus/hepatitis delta virus co-infection, the method comprising administering to a subject in need of such treatment a first pharmaceutically acceptable agent that comprises at least one phosphorothioated nucleic acid polymer and a second pharmaceutically acceptable agent that comprises at least one nucleoside/nucleotide analog HBV polymerase inhibitor. | ||
| 申请公布号 | US9603865(B2) | 申请公布日期 | 2017.03.28 |
| 申请号 | US201514794129 | 申请日期 | 2015.07.08 |
| 申请人 | REPLICOR INC. | 发明人 | Vaillant Andrew |
| 分类号 | A61K48/00;C07H21/02;C07H21/04;A61K31/7125;A61K31/522;A61K31/683;A61K45/06;A61K31/675;A61K31/7088 | 主分类号 | A61K48/00 |
| 代理机构 | Norton Rose Fulbright Canada | 代理人 | Norton Rose Fulbright Canada |
| 主权项 | 1. A method for treating HBV infection or HBV/HDV co-infection in a subject comprising administering a first pharmaceutically acceptable agent which comprises a chelate complex of at least one phosphorothioated nucleic acid polymer and a second pharmaceutically acceptable agent which comprises at least one nucleoside/nucleotide analog HBV polymerase inhibitor. | ||
| 地址 | Montreal QC CA | ||